Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.

Andrew Menzies-Gow,Mark Gurnell,Liam G Heaney,Jonathan Corren,Elisabeth H Bel,Jorge Maspero,Timothy Harrison,David J Jackson,David Price,Njira Lugogo,James Kreindler,Annie Burden,Alex de Giorgio-Miller, Sarai Faison,Kelly Padilla,Ubaldo J Martin,Esther Garcia Gil

The European respiratory journal（2022）

引用 6|浏览16

暂无评分

摘要

Most patients successfully maintained maximal OCS reduction while achieving improved asthma control with few exacerbations and maintaining or recovering adrenal function.

查看译文

关键词

durable oral corticosteroid sparing,adrenal function recovery,benralizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要